Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.

McClure BJ, Heatley SL, Kok CH, Sadras T, An J, Hughes TP, Lock RB, Yeung D, Sutton R, White DL.

Br J Cancer. 2018 Apr;118(7):1000-1004. doi: 10.1038/s41416-018-0022-0. Epub 2018 Mar 13.

PMID:
29531323
2.

A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.

Sadras T, Heatley SL, Kok CH, McClure BJ, Yeung D, Hughes TP, Sutton R, Ziegler DS, White DL.

Cancer Genet. 2017 Oct;216-217:86-90. doi: 10.1016/j.cancergen.2017.07.008. Epub 2017 Jul 31.

PMID:
29025600
3.

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, McClure B, Venn N, Moore S, Suttle J, Law T, Ng A, Muskovic W, Norris MD, Revesz T, Osborn M, Moore AS, Suppiah R, Fraser C, Alvaro F, Hughes TP, Mullighan CG, Marshall GM, Pozza LD, Yeung DT, Sutton R, White DL.

Haematologica. 2017 Dec;102(12):e490-e493. doi: 10.3324/haematol.2016.162925. Epub 2017 Sep 21. No abstract available.

4.

Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.

Sadras T, Heatley SL, Kok CH, Dang P, Galbraith KM, McClure BJ, Muskovic W, Venn NC, Moore S, Osborn M, Revesz T, Moore AS, Hughes TP, Yeung D, Sutton R, White DL.

Cancer Lett. 2017 Nov 1;408:92-101. doi: 10.1016/j.canlet.2017.08.034. Epub 2017 Sep 1.

PMID:
28866095
5.

A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia.

Pagani IS, Kok CH, Saunders VA, Van der Hoek MB, Heatley SL, Schwarer AP, Hahn CN, Hughes TP, White DL, Ross DM.

J Mol Diagn. 2017 Sep;19(5):711-721. doi: 10.1016/j.jmoldx.2017.05.009. Epub 2017 Jul 18.

PMID:
28732215
6.

A Multifaceted Quality Improvement Programme to Improve Acute Kidney Injury Care and Outcomes in a Large Teaching Hospital.

Ebah L, Hanumapura P, Waring D, Challiner R, Hayden K, Alexander J, Henney R, Royston R, Butterworth C, Vincent M, Heatley S, Terriere G, Pearson R, Hutchison A.

BMJ Qual Improv Rep. 2017 May 25;6(1). pii: u219176.w7476. doi: 10.1136/bmjquality.u219176.w7476. eCollection 2017.

7.

COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.

Lopes BA, Meyer C, Barbosa TC, Zur Stadt U, Horstmann M, Venn NC, Heatley S, White DL, Sutton R, Pombo-de-Oliveira MS, Marschalek R, Emerenciano M.

Oncotarget. 2016 Aug 16;7(33):53064-53073. doi: 10.18632/oncotarget.10590.

8.

Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant.

Richmond J, Robbins A, Evans K, Beck D, Kurmasheva RT, Billups CA, Carol H, Heatley S, Sutton R, Marshall GM, White D, Pimanda J, Houghton PJ, Smith MA, Lock RB.

Cancer Res. 2016 Aug 1;76(15):4579-91. doi: 10.1158/0008-5472.CAN-16-0523. Epub 2016 Jun 14.

9.

Characterization of leukemias with ETV6-ABL1 fusion.

Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, Heatley SL, Loh ML, Konopleva M, Chen IM, Zimmermannova O, Schwab C, Smith O, Mozziconacci MJ, Chabannon C, Kim M, Frederik Falkenburg JH, Norton A, Marshall K, Haas OA, Starkova J, Stuchly J, Hunger SP, White D, Mullighan CG, Willman CL, Stary J, Trka J, Zuna J.

Haematologica. 2016 Sep;101(9):1082-93. doi: 10.3324/haematol.2016.144345. Epub 2016 May 26.

10.

Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL.

Trahair TN, Lock RB, Sutton R, Sia KC, Evans K, Richmond J, Law T, Venn NC, Irving JA, Moore S, Nievergall E, Dang P, Heatley SL, White DL, Revesz T.

Bone Marrow Transplant. 2016 Sep;51(9):1279-82. doi: 10.1038/bmt.2016.122. Epub 2016 May 16. No abstract available.

PMID:
27183096
11.

Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.

Dolai S, Sia KC, Robbins AK, Zhong L, Heatley SL, Vincent TL, Hochgräfe F, Sutton R, Kurmasheva RT, Revesz T, White DL, Houghton PJ, Smith MA, Teachey DT, Daly RJ, Raftery MJ, Lock RB.

Cancer Res. 2016 Mar 9. pii: canres.2786.2015. [Epub ahead of print]

PMID:
26960974
12.

Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.

Yeung DT, Moulton DJ, Heatley SL, Nievergall E, Dang P, Braley J, Branford S, Moore S, Mullighan CG, Hughes TP, White DL.

Leukemia. 2015 Jan;29(1):230-2. doi: 10.1038/leu.2014.256. Epub 2014 Sep 2. No abstract available.

PMID:
25179732
13.

Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.

Sadras T, Perugini M, Kok CH, Iarossi DG, Heatley SL, Brumatti G, Samuel MS, To LB, Lewis ID, Lopez AF, Ekert PG, Ramshaw HS, D'Andrea RJ.

J Leukoc Biol. 2014 Jul;96(1):83-91. doi: 10.1189/jlb.2AB1013-559R. Epub 2014 Mar 5.

PMID:
24598054
14.

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.

15.

The genomic landscape of hypodiploid acute lymphoblastic leukemia.

Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, Heatley SL, Phillips LA, Song G, Easton J, Parker M, Chen X, Rusch M, Boggs K, Vadodaria B, Hedlund E, Drenberg C, Baker S, Pei D, Cheng C, Huether R, Lu C, Fulton RS, Fulton LL, Tabib Y, Dooling DJ, Ochoa K, Minden M, Lewis ID, To LB, Marlton P, Roberts AW, Raca G, Stock W, Neale G, Drexler HG, Dickins RA, Ellison DW, Shurtleff SA, Pui CH, Ribeiro RC, Devidas M, Carroll AJ, Heerema NA, Wood B, Borowitz MJ, Gastier-Foster JM, Raimondi SC, Mardis ER, Wilson RK, Downing JR, Hunger SP, Loh ML, Mullighan CG.

Nat Genet. 2013 Mar;45(3):242-52. doi: 10.1038/ng.2532. Epub 2013 Jan 20.

16.

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG.

Nature. 2012 Jan 11;481(7380):157-63. doi: 10.1038/nature10725.

17.

CREST maps somatic structural variation in cancer genomes with base-pair resolution.

Wang J, Mullighan CG, Easton J, Roberts S, Heatley SL, Ma J, Rusch MC, Chen K, Harris CC, Ding L, Holmfeldt L, Payne-Turner D, Fan X, Wei L, Zhao D, Obenauer JC, Naeve C, Mardis ER, Wilson RK, Downing JR, Zhang J.

Nat Methods. 2011 Jun 12;8(8):652-4. doi: 10.1038/nmeth.1628.

18.

High levels of mannose-binding lectin are associated with poor outcomes after lung transplantation.

Carroll KE, Dean MM, Heatley SL, Meehan AC, Mifsud NA, Kotsimbos TC, Snell GI, Westall GP.

Transplantation. 2011 May 15;91(9):1044-9. doi: 10.1097/TP.0b013e318212c7d6.

PMID:
21394075
19.

CREBBP mutations in relapsed acute lymphoblastic leukaemia.

Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, Buetow KH, Pui CH, Baker SD, Brindle PK, Downing JR.

Nature. 2011 Mar 10;471(7337):235-9. doi: 10.1038/nature09727.

20.

Optimal referral is early referral.

Heatley SA.

Perit Dial Int. 2009 Feb;29 Suppl 2:S128-31. Review.

PMID:
19270201
21.

Optimal referral to pre-dialysis services: one center's experience.

Heatley SA.

Perit Dial Int. 2009 Feb;29 Suppl 2:S115-6. Review.

PMID:
19270198
22.

Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation.

Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, Tung JP, Scott J, Padbury RT, Harley HA, Bardy PG, Angus PW, Mullighan CG.

Clin Infect Dis. 2009 Feb 15;48(4):410-7. doi: 10.1086/596313.

PMID:
19143554
23.

Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation.

Mullighan CG, Heatley SL, Danner S, Dean MM, Doherty K, Hahn U, Bradstock KF, Minchinton R, Schwarer AP, Szer J, Bardy PG.

Blood. 2008 Sep 1;112(5):2120-8. doi: 10.1182/blood-2007-07-100222. Epub 2008 Jun 13.

24.

Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients.

Eisen DP, Dean MM, O'Sullivan MV, Heatley S, Minchinton RM.

Med Mycol. 2008 Jun;46(4):371-5. doi: 10.1080/13693780701874515.

PMID:
18415846
25.

The impact of pre-entry study skills training programmes on students' first year experience in health and social care programmes.

Fergy S, Heatley S, Morgan G, Hodgson D.

Nurse Educ Pract. 2008 Jan;8(1):20-30. Epub 2007 Apr 18.

PMID:
18086450
26.

[Patient education in pre-dialysis -- patient-led forums].

Heatley SA.

J Ren Care. 2006 Jul-Sep;32(3):186-8. German.

PMID:
17393817
27.

Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity.

Worthley DL, Mullighan CG, Dean MM, Gordon DL, Phillips P, Heatley S, Young GP, Bardy PG.

Eur J Gastroenterol Hepatol. 2007 Feb;19(2):147-52.

PMID:
17273000
28.

Low mannose-binding lectin function is associated with sepsis in adult patients.

Eisen DP, Dean MM, Thomas P, Marshall P, Gerns N, Heatley S, Quinn J, Minchinton RM, Lipman J.

FEMS Immunol Med Microbiol. 2006 Nov;48(2):274-82.

29.

Mannose binding lectin acute phase activity in patients with severe infection.

Dean MM, Minchinton RM, Heatley S, Eisen DP.

J Clin Immunol. 2005 Jul;25(4):346-52.

PMID:
16133991
30.

Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function.

Dean MM, Heatley S, Minchinton RM.

Mol Immunol. 2006 Mar;43(7):950-61. Epub 2005 Aug 11.

PMID:
16099048
31.

Polymorphisms in immunoregulatory genes and the risk of histologic chorioamnionitis in Caucasoid women: a case control study.

Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, McDonald HM.

BMC Pregnancy Childbirth. 2005 Feb 21;5(1):4.

32.

Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth.

Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM.

Am J Obstet Gynecol. 2004 Dec;191(6):2056-67.

PMID:
15592292
33.

Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.

Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T, Schwarer A, Szer J, Tait B, To B, Bardy P.

Transplantation. 2004 Feb 27;77(4):587-96.

PMID:
15084940
34.

Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.

Heatley S.

Int J Palliat Nurs. 2004 Jan;10(1):41-6. Review.

PMID:
14966444
35.

Fas gene promoter polymorphisms in primary Sjögren's syndrome.

Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG.

Ann Rheum Dis. 2004 Jan;63(1):98-101.

36.

Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome.

Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP.

Genes Immun. 2003 Jan;4(1):82-5.

PMID:
12595908
37.

Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population.

Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG.

Scand J Immunol. 2002 Dec;56(6):630-41.

38.

Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.

Heatley S.

Int J Palliat Nurs. 2001 Jun;7(6):301-2, 304-7. Review.

PMID:
12066026
39.

Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation.

Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP, Schwarer AP, Szer J, Tait BD, Bik To L, Bardy PG.

Blood. 2002 May 15;99(10):3524-9.

40.
41.

Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblings.

Tait BD, Maddison R, McCluskey J, Deayton S, Heatley S, Lester S, Bardy P, Szer J, Grigg A, Spencer A, Schwarer A, Holdsworth R.

Transplant Proc. 2001 Feb-Mar;33(1-2):1760-1. No abstract available.

PMID:
11267501
42.

Lack of association between mannose-binding lectin gene polymorphisms and primary Sjögren's syndrome.

Mullighan CG, Heatley S, Bardy PG, Lester S, Rischmueller M, Gordon TP.

Arthritis Rheum. 2000 Dec;43(12):2851-2. No abstract available.

43.

Are higher doses of nicotine replacement more effective for smoking cessation?

Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, Rennard SI, Wadland WC, Heatley SA.

Nicotine Tob Res. 1999 Jun;1(2):169-74.

PMID:
11072398
44.

Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians.

Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, McCluskey J, Roberton D.

Hum Mol Genet. 2000 Jun 12;9(10):1481-6.

PMID:
10888598
45.

The DD genotype of the angiotensin-converting enzyme gene occurs in very low frequency in Australian Aboriginals.

Lester S, Heatley S, Bardy P, Bahnisch J, Bannister K, Faull R, Clarkson A.

Nephrol Dial Transplant. 1999 Apr;14(4):887-90.

PMID:
10328464
46.

The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.

Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI.

Prev Med. 1999 Feb;28(2):113-8.

PMID:
10048102
47.

[Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].

Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, De Blasio F, et al.

Arch Monaldi Mal Torace. 1992 Jan-Dec;47(1-6):17-29. Italian.

PMID:
1306633
48.

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, Rennard SI.

Arch Intern Med. 1991 Apr;151(4):749-52.

PMID:
2012458
49.

Medical schools and the government.

Lyon NC, Heatley SA, VAN Pelt J 3rd, DE LA Torre J, Vernick S.

Science. 1977 Oct 14;198(4313):122-3. No abstract available.

PMID:
17755337
50.

Lymphocyte transformation initiated by galactose oxidase coupled to latex microspheres and formalinized erythrocytes.

Heatley SA, Gordon IL, O'Brien RL, Rembaum A, Parker JW.

Exp Cell Res. 1977 Aug;108(1):139-49. No abstract available.

PMID:
891627

Supplemental Content

Loading ...
Support Center